The care of older cancer patients in the United Kingdom.

United Kingdom cancer geriatric oncology older patients

Journal

Ecancermedicalscience
ISSN: 1754-6605
Titre abrégé: Ecancermedicalscience
Pays: England
ID NLM: 101392236

Informations de publication

Date de publication:
2020
Historique:
received: 20 04 2020
entrez: 21 10 2020
pubmed: 22 10 2020
medline: 22 10 2020
Statut: epublish

Résumé

The ageing population poses new challenges globally. Cancer care for older patients is one of these challenges, and it has a significant impact on societies. In the United Kingdom (UK), as the number of older cancer patients increases, the management of this group has become part of daily practice for most oncology teams in every geographical area. Older cancer patients are at a higher risk of both under- and over-treatment. Therefore, the assessment of a patient's biological age and effective organ functional reserve becomes paramount. This may then guide treatment decisions by better estimating a prognosis and the risk-to-benefit ratio of a given therapy to anticipate and mitigate against potential toxicities/difficulties. Moreover, older cancer patients are often affected by geriatric syndromes and other issues that impact their overall health, function and quality of life. Comprehensive geriatric assessments offer an opportunity to identify and address health problems which may then optimise one's fitness and well-being. Whilst it is widely accepted that older cancer patients may benefit from such an approach, resources are often scarce, and access to dedicated services and research remains limited to specific centres across the UK. The aim of this project is to map the current services and projects in the UK to learn from each other and shape the future direction of care of older patients with cancer.

Identifiants

pubmed: 33082851
doi: 10.3332/ecancer.2020.1101
pii: can-14-1101
pmc: PMC7532033
doi:

Types de publication

Journal Article Review

Langues

eng

Pagination

1101

Informations de copyright

© the authors; licensee ecancermedicalscience.

Déclaration de conflit d'intérêts

The authors declare that they have no conflicts of interest.

Références

J Geriatr Oncol. 2020 Mar;11(2):244-255
pubmed: 31492572
Br J Cancer. 2012 Sep 25;107(7):1195-202
pubmed: 22892390
Br J Cancer. 2015 Apr 28;112(9):1435-44
pubmed: 25871332
CMAJ. 2005 Aug 30;173(5):489-95
pubmed: 16129869
BMC Med. 2015 Jul 13;13:161
pubmed: 26166298
BJGP Open. 2018 Oct 17;2(4):bjgpopen18X101608
pubmed: 30723794
Eur J Radiol. 2018 Dec;109:142-146
pubmed: 30527297
BMJ Open. 2017 Jul 31;7(7):e015133
pubmed: 28760787
J Geriatr Oncol. 2019 Jan;10(1):175-177
pubmed: 30041980
Eur J Surg Oncol. 2020 May 1;:
pubmed: 32439265
J Geriatr Oncol. 2019 May;10(3):382-383
pubmed: 30765269
World J Clin Oncol. 2020 Mar 24;11(3):152-161
pubmed: 32257846
Int J Nurs Stud. 2017 Jan;65:A1-A2
pubmed: 27884390
J Geriatr Oncol. 2019 May;10(3):378-381
pubmed: 30846282
Eur J Cancer Care (Engl). 2017 Sep;26(5):
pubmed: 27132979

Auteurs

Fabio Gomes (F)

The Christie NHS Foundation Trust, Manchester M20 4BX, UK.

Anna Lewis (A)

Nottingham University Hospitals NHS Trust, Nottingham NG5 1PB, UK.

Rob Morris (R)

Nottingham University Hospitals NHS Trust, Nottingham NG5 1PB, UK.

Ruth Parks (R)

School of Medicine, University of Nottingham, Nottingham NG7 2UH, UK.

Tania Kalsi (T)

Guy's and St. Thomas' NHS Foundation Trust, London SE1 9RS, UK.
King's College London, London SE5 9RS, UK.

Gordana Babic-Illamn (G)

Guy's and St. Thomas' NHS Foundation Trust, London SE1 9RS, UK.

Mark Baxter (M)

Ninewells Hospital, NHS Tayside, Dundee DD2 1SG, UK.

Kirsty Colquhoun (K)

Beatson West of Scotland Cancer Centre, NHS Greater Glasgow and Clyde, Glasgow G12 0YN, UK.

Lisa Rodgers (L)

Beatson West of Scotland Cancer Centre, NHS Greater Glasgow and Clyde, Glasgow G12 0YN, UK.

Eleanor Smith (E)

The Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne NE7 7DN, UK.

Alastair Greystoke (A)

The Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne NE7 7DN, UK.

Neil Bayman (N)

The Christie NHS Foundation Trust, Manchester M20 4BX, UK.

Anthea Cree (A)

The Christie NHS Foundation Trust, Manchester M20 4BX, UK.

Cassandra Ng (C)

Wythenshawe Hospital, Manchester University NHS Foundation Trust, Manchester M23 9LT, UK.

Nicola de Liguori Carino (N)

Royal Manchester Infirmary, Manchester University NHS Foundation Trust, Manchester M13 9WL, UK.

Simone Basile (S)

Royal Manchester Infirmary, Manchester University NHS Foundation Trust, Manchester M13 9WL, UK.

John Moore (J)

Royal Manchester Infirmary, Manchester University NHS Foundation Trust, Manchester M13 9WL, UK.

Zoe Merchant (Z)

Greater Manchester Cancer, Manchester M20 4BX, UK.

Daniel Swinson (D)

Leeds Teaching Hospitals NHS Trust, Leeds LS1 3EX, UK.

Anita Parbhoo (A)

South West Wales Cancer Centre, Swansea Bay University Health Board, Swansea SA2 8QA, UK.

Rachel Jones (R)

South West Wales Cancer Centre, Swansea Bay University Health Board, Swansea SA2 8QA, UK.

Eleri Davies (E)

University Hospital of Llandough, Cardiff and Vale University Health Board, Cardiff CF64 2XX, UK.

Sarah J Danson (SJ)

Department of Oncology and Metabolism, The Medical School, University of Sheffield, Sheffield S10 2RX, UK.

Robin Young (R)

Department of Oncology and Metabolism, The Medical School, University of Sheffield, Sheffield S10 2RX, UK.

Jenna Morgan (J)

Department of Oncology and Metabolism, The Medical School, University of Sheffield, Sheffield S10 2RX, UK.

Lynda Wyld (L)

Department of Oncology and Metabolism, The Medical School, University of Sheffield, Sheffield S10 2RX, UK.

Pippa G Corrie (PG)

Cambridge University Hospitals NHS Foundation Trust, Cambridge CB2 0QQ, UK.

Gary J Doherty (GJ)

Cambridge University Hospitals NHS Foundation Trust, Cambridge CB2 0QQ, UK.

Kyle Crawford (K)

Belfast Health and Social Care Trust, Belfast BT13 1FD, UK.

Juliet Wright (J)

Brighton and Sussex Medical School, University of Brighton, Brighton BN1 9PX, UK.

Malcolm Reed (M)

Brighton and Sussex Medical School, University of Brighton, Brighton BN1 9PX, UK.

Fiammetta Ugolini (F)

Sussex Cancer Centre, Brighton and Sussex University Hospitals NHS Trust, Sussex BN2 5BD, UK.

Michael Lind (M)

Queen's Centre for Oncology and Haematology, Hull University Teaching Hospitals NHS Trust, Hull HU16 5JQ, UK.

Kwok-Leung Cheung (KL)

School of Medicine, University of Nottingham, Nottingham NG7 2UH, UK.
Co-senior authorship.

Danielle Harari (D)

Guy's and St. Thomas' NHS Foundation Trust, London SE1 9RS, UK.
King's College London, London SE5 9RS, UK.
Co-senior authorship.

Richard Simcock (R)

Sussex Cancer Centre, Brighton and Sussex University Hospitals NHS Trust, Sussex BN2 5BD, UK.
Co-senior authorship.

Classifications MeSH